论文部分内容阅读
丹参素是丹参水溶性有效成份。本实验研究丹参素制剂对兔实验性心肌梗塞范围的作用,并与具有缩小梗塞范围的丹参制剂以及西药心得安进行比较,结果作用相同。试用丹参素肌注治疗冠心病22例,取得较好的疗效,症状改善率82%;冠心病心肌供血不足患者心电图好转率66%;与复方丹参注射液治疗冠心病患者相比,疗效基本一致,心电图疗效略高于复方丹参注射液,这说明丹参素的确是丹参的有效成分之一。
Danshensu is a water-soluble active ingredient of Salvia miltiorrhiza. This experiment studied the effect of Danshensu preparation on the experimental myocardial infarction range in rabbits, and compared it with the Danshen preparation with reduced infarct size and the western medicine propranolol, and the results were the same. Trial of Danshensu intramuscular injection in the treatment of coronary heart disease in 22 cases, to achieve better results, the improvement rate of symptoms was 82%; coronary heart disease in patients with myocardial insufficiency ECG improvement rate of 66%; compared with compound Danshen injection in patients with coronary heart disease, the efficacy is basically the same, The efficacy of electrocardiogram is slightly higher than that of compound Danshen injection, indicating that Danshensu is indeed one of the effective components of Danshen.